Team

 

Dr Gillies O’Bryan-Tear, PhD
Non-Executive Director

Dr O’Bryan-Tear joined the Board in April 2019 as a Non-Executive Director.

Dr O’Bryan-Tear has over 30 years of experience in the pharmaceutical industry in clinical development, medical management and commercial roles. He has held senior leadership roles in large and small pharmaceutical and biotech companies in the US and Europe and has been involved in multiple product approvals. He was previously the Chief Medical Officer of Algeta ASA. Dr O’Bryan-Tear has been an adviser to several US and European biotech companies and is a member of the Scientific Advisory Board of Fusion Pharmaceuticals Inc. (Canada).

Dr O’Bryan-Tear obtained his Doctor of Medicine degrees from the Universities of Cambridge